DK1304104T3 - Tablet omfattende en phosphatbindende polymer - Google Patents

Tablet omfattende en phosphatbindende polymer

Info

Publication number
DK1304104T3
DK1304104T3 DK02025683T DK02025683T DK1304104T3 DK 1304104 T3 DK1304104 T3 DK 1304104T3 DK 02025683 T DK02025683 T DK 02025683T DK 02025683 T DK02025683 T DK 02025683T DK 1304104 T3 DK1304104 T3 DK 1304104T3
Authority
DK
Denmark
Prior art keywords
phosphate
binding polymer
tablet
particle size
less
Prior art date
Application number
DK02025683T
Other languages
Danish (da)
English (en)
Inventor
Katsuya Matsuda
Ryuji Kubota
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1304104T3 publication Critical patent/DK1304104T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK02025683T 1997-04-04 1998-04-03 Tablet omfattende en phosphatbindende polymer DK1304104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8658197 1997-04-04
PCT/JP1998/001536 WO1998044933A1 (fr) 1997-04-04 1998-04-03 Preparations polymeres se fixant au phosphate

Publications (1)

Publication Number Publication Date
DK1304104T3 true DK1304104T3 (da) 2007-07-16

Family

ID=13890981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02025683T DK1304104T3 (da) 1997-04-04 1998-04-03 Tablet omfattende en phosphatbindende polymer

Country Status (16)

Country Link
US (2) US6383518B1 (de)
EP (2) EP1304104B1 (de)
JP (2) JP2009173687A (de)
KR (1) KR100456202B1 (de)
CN (1) CN1180782C (de)
AT (2) ATE364377T1 (de)
AU (1) AU726142B2 (de)
CA (1) CA2286003C (de)
CY (1) CY1106823T1 (de)
DE (2) DE69816082T2 (de)
DK (1) DK1304104T3 (de)
ES (2) ES2201463T3 (de)
HK (2) HK1027506A1 (de)
PT (1) PT1304104E (de)
TW (1) TW592727B (de)
WO (1) WO1998044933A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
JP3718341B2 (ja) * 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
EE200200209A (et) * 1999-10-19 2003-06-16 Geltex Pharmaceuticals, Inc. Otsese pressimisega valmistatud polümeerne tabletisüdamik
US6680069B1 (en) 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (ja) 2000-01-14 2004-08-11 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース粒子の形成方法
WO2002066543A1 (en) 2001-02-16 2002-08-29 Genzyme Corporation Method of drying a material having a cohesive phase
CA2444587C (en) 2001-04-18 2008-10-21 Genzyme Corporation Pharmaceutical compositions of low salt polyallylamine hydrochloride
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
AU2002257145B2 (en) 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
FR2827771B1 (fr) * 2001-07-25 2003-10-24 Apis Spheromont Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
TWI231760B (en) * 2001-12-20 2005-05-01 Chugai Pharmaceutical Co Ltd Coated lozenge and manufacturing method thereof
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
EP1869090A1 (de) * 2005-03-16 2007-12-26 Council Of Scientific And Industrial Research Verbessertes verfahren zur herstellung eines vernetzten polyallylaminpolymers
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0601899D0 (en) * 2006-01-31 2006-03-08 Ineos Silicas Ltd Compositions
CA2642255A1 (en) 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
DK1818048T3 (da) * 2006-02-14 2009-04-20 Teva Pharma Farmaceutiske formuleringer af alifatiske aminpolymerer og metoder til deres fremstilling
WO2007130463A2 (en) * 2006-05-05 2007-11-15 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
CA2658338A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
US7964182B2 (en) 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
US8187634B2 (en) 2006-09-01 2012-05-29 Usv, Ltd. Process for the preparation of sevelamer hydrochloride and formulation thereof
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
EP2120972A1 (de) 2006-12-14 2009-11-25 Genzyme Corporation Amido-amin-polymerzusammensetzungen
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
EP2131820A1 (de) * 2007-03-08 2009-12-16 Genzyme Corporation Sulfonpolymerzusammensetzungen
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
JP2011506449A (ja) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
BRPI1006969A2 (pt) * 2009-01-22 2016-04-12 Usv Ltd composições farmacêuticas compreendendo polímero de ligação a fosfato
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
EA024699B1 (ru) * 2009-10-22 2016-10-31 Синтон Б. В. Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
EP2545907A1 (de) 2011-07-15 2013-01-16 Combino Pharm, S.L. Verfahren zur wässrig-nassen Granulation für vernetzte Polyallylaminpolymere
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
US20180015119A1 (en) * 2015-02-23 2018-01-18 Amneal Pharmaceuticals Company Gmbh Process for granulating sevelamer carbonate
AU2017388956A1 (en) 2016-12-28 2019-07-11 Fujifilm Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
EP3698798A4 (de) * 2017-10-16 2020-12-23 FUJIFILM Corporation Mittel zur behandlung von hyperphosphatämie und partikel
EP3698799B1 (de) 2017-10-16 2022-01-26 FUJIFILM Corporation Mittel zur behandlung von hyperphosphatämie
JP2019182818A (ja) * 2018-04-17 2019-10-24 ライオン株式会社 舌苔除去用の口腔内崩壊錠及び舌苔除去方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
US4631305A (en) 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
EP0273209B1 (de) * 1986-12-30 1992-01-15 American Cyanamid Company Zusammensetzung die ein Polycarbophil enthält
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
JPH02286621A (ja) 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
JPH0413627A (ja) * 1990-04-27 1992-01-17 Mitsubishi Kasei Corp 経口コレステロール低下剤
JP2609022B2 (ja) 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
TW272942B (de) 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3836893B2 (ja) 1995-01-24 2006-10-25 アボットジャパン株式会社 ポリカルボフィルカルシウム含有製剤
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤

Also Published As

Publication number Publication date
AU6522398A (en) 1998-10-30
DE69837945T2 (de) 2008-02-21
KR20010005980A (ko) 2001-01-15
ATE244013T1 (de) 2003-07-15
DE69816082D1 (de) 2003-08-07
EP1304104B1 (de) 2007-06-13
US6696087B2 (en) 2004-02-24
CN1180782C (zh) 2004-12-22
HK1055387A1 (en) 2004-01-09
KR100456202B1 (ko) 2004-11-09
EP1304104A2 (de) 2003-04-23
JP2013010803A (ja) 2013-01-17
EP0997148A4 (de) 2000-05-03
EP1304104A3 (de) 2003-11-12
AU726142B2 (en) 2000-11-02
HK1027506A1 (en) 2001-01-19
DE69816082T2 (de) 2004-04-15
US20020122786A1 (en) 2002-09-05
CA2286003C (en) 2007-06-05
WO1998044933A1 (fr) 1998-10-15
CY1106823T1 (el) 2012-05-23
EP0997148B1 (de) 2003-07-02
US6383518B1 (en) 2002-05-07
EP0997148A1 (de) 2000-05-03
JP2009173687A (ja) 2009-08-06
CN1254287A (zh) 2000-05-24
JP5681156B2 (ja) 2015-03-04
CA2286003A1 (en) 1998-10-15
TW592727B (en) 2004-06-21
PT1304104E (pt) 2007-07-27
ES2287215T3 (es) 2007-12-16
DE69837945D1 (de) 2007-07-26
ATE364377T1 (de) 2007-07-15
ES2201463T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
DK1304104T3 (da) Tablet omfattende en phosphatbindende polymer
EP1153940A4 (de) Polymer mit phosphorsäure und mischungen diese enthaltend
JPH11512067A (ja) 表面改質炭酸カルシウム組成物およびその使用
US6083317A (en) Stabilized calcium carbonate composition using sodium silicate and one or more weak acids or alum and uses therefor
GR1002094B (en) Process for the preparation of aqueous suspension for substantially water in sowble actives
BR9714124A (pt) Pasta de carbonato de cálcio estabilizada com ácido para uso na fabricação de papel ácido, processos para fabricação de uma pasta de carbonato de cálcio possuindo um ph de menos de 7 e para formação de um papel com carga, e, papel ácido com carga
CA2306257A1 (en) 5-azaquinoxaline-based compounds and modulation of serine/threonine protein kinase function
DE69939555D1 (de) Granuliertes Brotverbesserungmittel zur Herstellung von Teigwaren
AU699931B2 (en) Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
CA2468740A1 (en) Papermaking process using enzyme-treated sludge, and products
TW334487B (en) Acid tolerant calcium carbonate composition and uses therefor
JPH11513659A (ja) アルミニウムまたはマグネシウムの水酸化物を含む耐酸性炭酸塩組成物及びその使用
EA199900917A2 (ru) Способ получения монодисперсных гелеобразных анионитов
EP0361763A3 (de) Füllerzusammensetzung für die Papierherstellung
CA2495006A1 (en) Methods for modifying electrical properties of papermaking compositions using carbon dioxide
JPH11514325A (ja) 耐酸性炭酸カルシウム填料
JPS63195115A (ja) 変性炭酸カルシウム
JPH01281050A (ja) 大豆繊維質粉末物質
JPS609996A (ja) 填料の抄紙方法
JPH10305087A (ja) セルロース系消臭剤の製造方法
RU98118645A (ru) Кислотоустойчивый карбонат кальция, способ приготовления кислотоустойчивого карбоната кальция, способ улучшения оптических свойств бумаги
JPS5674106A (en) Preparation of water-soluble polymer
CA2235010A1 (en) Acid resistant carbonate composition containing an aluminum or magnesium hydroxide and uses therefor
IT1245400B (it) Procedimento per la fabbricazione di polveri di fosfato di calcio, in particolare ca-idrossiapatite, costituite da particelle di forma irregolare o sferica, e prodotto relativo
TH24568A (th) "ส่วนประกอบของแคลเซียมคาร์บอเนตที่ทนกรดซึ่งประกอบด้วยเกลือของอลูมินัม และการนำไปใช้ของสารประกอบดังกล่าว "